GNRH1 and irritable bowel syndrome: We have now repeatedly described that patients with IBS and dysmotility express GnRH antibodies [8,16,17], but the effect of GnRH and/or its antibodies on the physiology and pathophysiology of the gastrointestinal tract remains to be determined.